期刊文献+

曼月乐联合加味地黄汤治疗单纯性子宫内膜增生 被引量:2

Mirena combined with Modified Dihuang Decoction in the Treatment of Simple Endometrial Hyperplasia
下载PDF
导出
摘要 目的探究曼月乐联合加味地黄汤治疗单纯性子宫内膜增生的疗效。方法选取我院2013年2月—2015年4月收治单纯性子宫内膜增生患者68例,随机分为观察组(37例)和对照组(31例),观察组给予曼月乐联合加味地黄汤治疗,对照组给予曼月乐治疗,对比两组治疗效果。结果观察组的总有效率为89.19%(33/37),对照组的总有效率为61.29%(19/31),观察组高于对照组,差异具有统计学意义(χ2=7.297,P<0.05);观察组不良反应发生率为5.41%(2/37),对照组不良反应发生率为25.81%(8/31),观察组低于对照组,差异具有统计学意义(P<0.05)。结论曼月乐联合加味地黄汤能有效改善患者子宫内膜增生情况,疗效显著,安全性高,具有较高的实用价值。 Objective To explore the effect of Mirena combined with modified Dihuang decoction in the treatment of simple endometrial hyperplasia. Methods 68 cases of patients with simple endometrial hyperplasia were selected from February 2013 to April 2015 in our hospital, and they were randomly divided into observation group (n = 37 ) and control group (n = 31 ). The observation group was treated with Mirena and modified Dihuang decoction. The control group was given Mirena treatment. We compared the therapeutic effect of the two groups. Results The total effective rate of the observation group was 89.19% (33/37) , the total effective rate of control group was 61.29% (19/31), the total effective rate of the observation group was higher than that of the control group, and the difference was statistically significant (X2 = 7. 297, P 〈 0. 05 ). The incidence of adverse reactions of the observation group was 5.41% (2/37) , and the adverse reaction rate of the control group was 25.81% (8/31) , the adverse reaction rate of the observation group was lower than that of the control group, and the difference was statistically significant ( P 〈 0.05 ). Conclusion Mirena combined with modified Dihuang decoction can effectively improve the situation of endometrial hyperplasia, the curative effect is distinct, and it has high safety and high practical value.
作者 魏立
出处 《光明中医》 2016年第22期3338-3339,共2页 GUANGMING JOURNAL OF CHINESE MEDICINE
关键词 曼月乐 单纯性子宫内膜增生 加味地黄汤 Mirena Simple endometrial hyperplasia Modified Dihuang decoction
  • 相关文献

参考文献6

二级参考文献37

  • 1邓姗,郎景和,冷金花,刘珠凤,孙大为,朱兰.曼月乐对子宫内膜异位症患者在位内膜增殖与凋亡的影响[J].生殖与避孕,2006,26(10):589-592. 被引量:114
  • 2金巧凤,赖爱鸾,张李松,杜强,冯向东.妇康片治疗子宫内膜单纯性增生的临床分析[J].首都医科大学学报,2007,28(5):652-654. 被引量:8
  • 3Mutter G, Zaino R, Baak J, et al. Benign endometrial hyperplasia se- quence and endometrial intraepithelial neoplasia [J]. Gynecol Pathol, 2007, 26 (2): 103-114. 被引量:1
  • 4Chrisman C, Ribeim P, Dalton VK. The lenvonorgestrel - releasing in- trauterine system: an updated review of the contraceptive and noneontra- ceptive uses [J]. Clin Obstet Gynecol, 2007, 50 (4): 886-897. 被引量:1
  • 5吴晓红,薛晓鸥,马秀丽,等.子宫内膜增生症的中医证型及用药特点分析[J].第八届全国中西医结合妇产科学术大会论文及摘要集,2012:297-298. 被引量:1
  • 6Higham J M, O'Brien P M S, Shaw R W. Assessment of menstrual blood loss using a pictorial chart[J]. Br J Obstetr Gynecol,1990,97(7): 734. 被引量:1
  • 7Orbo A, Ames M, Hancke C, et al. Treatment results of endometria 1 hyperplasia after prospective D-score classification:a follow-up study comparing effect of LNG-1UD and oral progestins versus observation only[J]. Gynecol Oncol,2008,111:68-73. 被引量:1
  • 8Hurskainen R, Salm iA, Paavonen J, et al. Expression of sexroid receptors and ki-67 in the endometria of menorrhagie women:effects of intrauterine levonorgestre [J]. Mol Hum Reprod,2000,6(11): 1013-1018. 被引量:1
  • 9Mutter G, Zaino R, Baak J, et al. Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia[J]. Gynecol Pathol ,2007,26(2): 103-114. 被引量:1
  • 10Chrisman C,Ribeiro P, Dalton VK. The lenvonorgestrel-releasing intrauterine system: an updated review of the contraceptive and noncontraceptive uses[J]. Clin Obstet Gynecol,2007,50(4):886-897. 被引量:1

共引文献24

同被引文献17

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部